The stock of iSpecimen Inc (ISPC) has seen a 2.50% increase in the past week, with a -22.35% drop in the past month, and a -22.05% decrease in the past quarter. The volatility ratio for the week is 6.45%, and the volatility levels for the past 30 days are at 6.61% for ISPC. The simple moving average for the last 20 days is -5.21% for ISPC stock, with a simple moving average of -61.27% for the last 200 days.
Is It Worth Investing in iSpecimen Inc (NASDAQ: ISPC) Right Now?
Additionally, the 36-month beta value for ISPC is 1.61. There are mixed opinions on the stock, with 1 analysts rating it as a “buy”, 0 rating it as “overweight”, 0 rating it as “hold”, and 0 rating it as “sell”.
The public float for ISPC is 2.14M and currently, short sellers hold a 1.93% ratio of that float. The average trading volume of ISPC on July 04, 2025 was 64.85K shares.
ISPC stock’s latest price update
The stock price of iSpecimen Inc (NASDAQ: ISPC) has plunged by -1.00% when compared to previous closing price of $1.0, but the company has seen a 2.50% gain in its stock price over the last five trading sessions. newsfilecorp.com reported 2025-01-16 that Woburn, Massachusetts–(Newsfile Corp. – January 16, 2025) – iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, has secured suppliers for the flu-like human metapneumovirus (hMPV). The virus has been causing hospitals in China to become overrun, raising the potential for another COVID-style pandemic.
ISPC Trading at -12.13% from the 50-Day Moving Average
After a stumble in the market that brought ISPC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.61% of loss for the given period.
Volatility was left at 6.61%, however, over the last 30 days, the volatility rate increased by 6.45%, as shares sank -20.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.50% lower at present.
During the last 5 trading sessions, ISPC rose by +2.50%, which changed the moving average for the period of 200-days by -74.33% in comparison to the 20-day moving average, which settled at $1.0445. In addition, iSpecimen Inc saw -83.67% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of iSpecimen Inc, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for ISPC
Current profitability levels for the company are sitting at:
- -1.41% for the present operating margin
- 0.31% for the gross margin
The net margin for iSpecimen Inc stands at -1.4%. The total capital return value is set at -5.91%. Equity return is now at value -265.37%, with -116.28% for asset returns.
Based on iSpecimen Inc (ISPC), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -24.28. The debt to equity ratio resting at 0.18. The interest coverage ratio of the stock is -48.14.
Currently, EBITDA for the company is -12.73 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 0.25. The receivables turnover for the company is 13.85for trailing twelve months and the total asset turnover is 1.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.31.
Conclusion
In conclusion, iSpecimen Inc (ISPC) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
